Learn more about how our customers use Datavant.
Understanding the Long Term Effectiveness of Varying Doses of a New Therapy for Major Depression
A large biopharmaceutical client conducted a Phase II, 6-week, randomized, placebo-controlled, dose-finding trial to evaluate the efficacy, tolerability and safety of a new oral medication in patients with major depressive disorder who were not responding to antidepressant therapy.
Trial Tokenization to Understand the Long Term Effectiveness of a New COVID-19 Vaccine
A biopharma company was conducting a Phase III study to assess the safety and effectiveness of a new COVID-19 vaccine. They needed to identify and connect to real-world data sources that would enable observation of infection rates and adverse events beyond the period of the trial.